Table 1 Demographic characteristics and growth outcomes of patients and controls
From: Homocysteine metabolism in children and adolescents with epidermolysis bullosa
EB patients (n = 20) | Controls (n = 20) | p * | |
|---|---|---|---|
Sex (M/F) | 12/8 | 12/8 | n.a. |
age (years) | 8.0;6.5-12.5 | 6.1;5.5-13 | 0.89 |
Growth outcomes | |||
Weight for agea | n = 20 | n = 20 | |
< 3 p | 35 % (7) | 10 % (2) | 0.13 |
3-10 p | 10 % (2) | 15 % (3) | 0.99 |
10-25 p | 15 % (3) | 10 % (2) | 0.99 |
25-50 p | 10 % (2) | 35 % (7) | 0.13 |
50-75 p | 20 % (4) | 15 % (3) | 0.99 |
75-90 p | 5 % (1) | 15 % (3) | 0.60 |
90-97 p | 5 % (1) | 0 % (0) | 0.99 |
Height for agea | n = 20 | n = 20 | |
< 3 p | 10 % (2) | 10 % (2) | 0.60 |
3-10 p | 20 % (4) | 20 % (4) | 0.60 |
10-25 p | 15 % (3) | 10 % (2) | 0.99 |
25-50 p | 25 % (5) | 20 % (4) | 0.99 |
50-75 p | 15 % (3) | 5 % (1) | 0.60 |
75-90 p | 10 % (2) | 15 % (3) | 0.99 |
90-97 p | 5 % (1) | 20 % (4) | 0.34 |
BMI (Kg/m2)a | n = 20 | n = 20 | |
< 3 p | 40 % (8) | 20 % (4) | 0.30 |
3-10 p | 5 % (1) | 15 % (3) | 0.60 |
10-25 p | 20 % (4) | 10 % (2) | 0.66 |
25-50 p | 20 % (4) | 20 % (4) | 0.69 |
50-75 p | 5 % (1) | 25 % (5) | 0.18 |
75-90 p | 0 % (0) | 10 % (2) | 0.47 |
90-95 p | 0 % (0) | 0 % (0) | n.a. |
95-97 p | 5 % (1) | 0 % (0) | 0.99 |
> 97 p | 5 % (1) | 0 % (0) | 0.99 |